Cancer is the second major cause of disease-related death worldwide, and its accurate
early diagnosis and therapeutic intervention are fundamental for saving the patient's life …

Background Insomnia is the most reported sleep disorder in industrialized countries,
affecting, in the chronic form, around 10% of the European population. In Italy, such a …

Objective The lack of current Canadian practice guidelines for the management of insomnia
poses a challenge for healthcare providers (HCP) in selecting the appropriate treatment …

Abstract Objective This Phase 3 double-blind, placebo-controlled study evaluated the
efficacy and safety of daridorexant in Japanese patients with insomnia disorder …

Introduction Insomnia is a common health problem and cognitive–behavioural therapy
(CBT) is recommended as a treatment. As there is a critical shortage of CBT-trained …

Objective To explore the preferences of medical practitioners concerning various
medications and other remedies to manage insomnia, and to ascertain whether these …

Biological, environmental, behavioral, and social factors can influence sleep and lead to
sleep disorders or diseases. Sleep disorders are common, numerous, and heterogeneous in …

Objective Insomnia disorder is a global public health issue, commonly treated with
hypnotics. However, long-term use of benzodiazepine derivatives (BZDs), especially …

Background When considering changing hypnotic pharmacotherapy, lemborexant has
attracted attention as a candidate due to its effectiveness and safety profile. However, few …

Introduction For patients with chronic insomnia, conventional therapy may not always
provide satisfactory efficacy and safety. Thus, switching to an alternative therapeutic agent …